In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss navigating CMC requirements for new modalities and AI ’s involvement in CMC.
News|Videos|April 3, 2025
INTERPHEX 2025: Beta Bags and Sterile Manufacturing
Author(s)Patrick Lavery, Susan Haigney
The Pharmaceutical Technology® Group sat down with Chris Gooding, general manager at CRL Solutions, to learn more about how beta bags assist in the transfer of supplies and equipment into a sterile environment.
Advertisement
Sterile manufacturing environments require that items be brought into the environment in a sterile manner. Traditionally, items would be taken through a transfer door into the sterile environment through a stainless-steel canister. Beta bags are a more flexible single-use method. To learn more about beta bags, the Pharmaceutical Technology® Group spoke with Chris Gooding, general manager at CRL Solutions, during INTERPHEX 2025, which is being held in New York City from April 1–3.
According to Gooding, products that need to be transferred to a sterile environment come in different sizes that require different sterilization methods, which has resulted in the development of new methods for transfer. Beta bags can be made longer or for different sterilization methods, therefore, making them convenient.
“The beta bag is really [designed] out of convenience for transferring either supplies, tools, or equipment into a sterile environment through an RTP [rapid transfer port] or a transfer door ... as opposed to the previous method, [which] would be a stainless-steel canister, but it was limited on the size and the depth and a number of different things,” Gooding says. “The bag allows it to be sized differently. It's much less expensive and is ultimately disposable after use.”
Click the video above to watch the interview.
About the speaker
Chris Gooding is the General Manager for Central Research Laboratories (CRL), headquartered in Red Wing, Minn. Chris has been the GM of CRL for five years. Prior to that, he worked in various leadership roles for many different manufacturing companies. CRL has 80 years of experience in the development of remote-handling systems, including telemanipulators, transfer systems, glove ports, and waste drum transfer systems. CRL's solutions promote operator safety and efficiency when performing various tasks in life sciences and nuclear applications around the world. For more information about CRL Solutions and its network of partners, visit
Advertisement
Related to this article
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discussed how CMC review practices are evolving and what that means for manufacturing strategy.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains that developing a molecule requires a holistic view of its chemical, physical, and biological properties.
On PharmTech.com this week, coverage of upcoming events continued, experts continued to discuss the use of AI in pharma, and validation in oral solid dosage product production was emphasized.
Advertisement
Advertisement